PH12019500934A1 - Opthalmic solution comprising epinastine - Google Patents

Opthalmic solution comprising epinastine

Info

Publication number
PH12019500934A1
PH12019500934A1 PH12019500934A PH12019500934A PH12019500934A1 PH 12019500934 A1 PH12019500934 A1 PH 12019500934A1 PH 12019500934 A PH12019500934 A PH 12019500934A PH 12019500934 A PH12019500934 A PH 12019500934A PH 12019500934 A1 PH12019500934 A1 PH 12019500934A1
Authority
PH
Philippines
Prior art keywords
epinastine
opthalmic solution
eye drops
antiseptic
opthalmic
Prior art date
Application number
PH12019500934A
Inventor
Masahiro Kawahata
Naoki Matsumoto
Hiroyuki Inoue
Tomoki Hara
Sachie Hikage
Takashi Morimoto
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of PH12019500934A1 publication Critical patent/PH12019500934A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides eye drops which contain epinastin or a salt thereof in a concentration exceeding 0.075 pcnt (w/v), the eye drops containing substantially no antiseptic or substantially no ingredient having antiseptic activity.
PH12019500934A 2016-10-28 2019-04-25 Opthalmic solution comprising epinastine PH12019500934A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016211535A JP6134853B1 (en) 2016-10-28 2016-10-28 Epinastine-containing ophthalmic solution
PCT/JP2017/038948 WO2018079721A1 (en) 2016-10-28 2017-10-27 Epinastin-containing eye drops

Publications (1)

Publication Number Publication Date
PH12019500934A1 true PH12019500934A1 (en) 2019-12-02

Family

ID=58745757

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12019500934A PH12019500934A1 (en) 2016-10-28 2019-04-25 Opthalmic solution comprising epinastine

Country Status (7)

Country Link
JP (1) JP6134853B1 (en)
KR (3) KR102659499B1 (en)
AU (1) AU2017348597A1 (en)
MY (1) MY192577A (en)
PH (1) PH12019500934A1 (en)
TW (1) TWI750248B (en)
WO (1) WO2018079721A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201841620A (en) * 2017-05-01 2018-12-01 日商參天製藥股份有限公司 Ophthalmic solution
JP7355539B2 (en) * 2018-07-20 2023-10-03 ロート製薬株式会社 Ophthalmic composition
JP7458159B2 (en) 2018-09-28 2024-03-29 ロート製薬株式会社 Ophthalmic Composition
JP2019108320A (en) * 2018-10-31 2019-07-04 参天製薬株式会社 Ophthalmologic composition which suppresses deterioration of soft contact lens
JP6736752B2 (en) * 2019-12-17 2020-08-05 参天製薬株式会社 Eye drops containing epinastine
JP2020169213A (en) * 2020-07-15 2020-10-15 参天製薬株式会社 Epinastine-containing eye drops

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (en) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Solutions containing epinastine
EP2664329A1 (en) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmological vehicle system
JPWO2015125921A1 (en) * 2014-02-20 2017-03-30 わかもと製薬株式会社 Pharmaceutical aqueous composition having storage efficacy

Also Published As

Publication number Publication date
KR20240054409A (en) 2024-04-25
JP6134853B1 (en) 2017-05-24
WO2018079721A1 (en) 2018-05-03
JP2018070500A (en) 2018-05-10
KR102491425B1 (en) 2023-01-20
MY192577A (en) 2022-08-29
AU2017348597A1 (en) 2019-05-16
KR20190075956A (en) 2019-07-01
TWI750248B (en) 2021-12-21
KR20230014870A (en) 2023-01-30
TW201821060A (en) 2018-06-16
KR102659499B1 (en) 2024-04-19

Similar Documents

Publication Publication Date Title
PH12019500934A1 (en) Opthalmic solution comprising epinastine
PH12017500837A1 (en) Container containing a nicotine solution
EA201890265A1 (en) HERBICID COMPOSITION CONTAINING ZINMETHYLINE AND METACHALOR
EA201890269A1 (en) HERBICID COMPOSITION CONTAINING ZINMETHYLINE AND NAPROPAMIDE
EA201890263A1 (en) HERBICID COMPOSITION CONTAINING ZINMETHYLINE AND METHOLOROR OR S-METHALHLOR
CL2016002815A1 (en) Aqueous ophthalmic solution and method to treat dry eye syndrome
EA201791467A1 (en) AQUEOUS OPHTHALMIC SOLUTION
MX2016013133A (en) Composition containing peroxide and an antimicrobial agent and process of killing spores.
PH12018500887A1 (en) Anti-htra1 antibodies and methods of use thereof
MX2018003554A (en) Isoxazoline-substituted benzamides and analogues as insecticides.
MX2016013155A (en) Process of killing spores using vaporuos peroxide composition.
MY187945A (en) Improved mouthwash preparation
NZ746468A (en) Methods of treating ocular conditions
PH12017501567A1 (en) Ophthalmic composition
WO2018189661A3 (en) Methods and compounds for treating diabetes
WO2015130547A8 (en) Bis-cyclic guanidine compound compositions, methods of use and treatment thereof
PH12016502386B1 (en) Oral care compositions
MX2019008338A (en) Pharmaceutical composition containing sulglycotide or pharmaceutically acceptable salt thereof for preventing or treating dry eye.
MX2020005242A (en) Agrochemical compositions.
EP3799567C0 (en) Eye drops comprising citric acid as the sole active ingredient
GB201208080D0 (en) Tobramycin formulation
WO2017066562A3 (en) Artificial metalloenzymes containing noble metal-porphyrins
WO2015108999A8 (en) Bioactive heme-haloperoxidase compositions and methods of their use
MX370865B (en) Low toxicity composition.
EA202190114A1 (en) METHODS FOR TREATMENT OF CLRN1-ASSOCIATED HEARING LOSS AND / OR VISION LOSS